Transforming growth factor β1 (TGF-β1) in patients with endocrine ophthalmopathy and Graves’ disease: A predictor of treatment efficiency

Current therapeutic approaches to the treatment of endocrine ophthalmopathy (EOP) are based on nonspecific immunosuppression with glucocorticosteroids (GCs) and radiation therapy of the eye orbits. However, some patients exhibit resistance to the treatment. In a previous study, we have detected high...

Description complète

Détails bibliographiques

Auteurs principaux:	N. Yu. Sviridenko, E. G. Bessmertnaya, I. M. Belovalova, M. S. Sheremeta, D. M. Babaeva, N. M. Malysheva, E. A. Troshina, G. A. Melnichenko
Format:	Artigo
Langue:	Russo
Publié:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2022-11-01
Collection:	Медицинская иммунология
Sujets:	graves’ disease endocrine ophthalmopathy cytokines antibodies glucocorticoids
Accès en ligne:	https://www.mimmun.ru/mimmun/article/view/2514
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!